Reverse Pitch: What Top Biotech VCs Are Looking For
Pitching session summary
In this unique session, leading biotech VCs pitch their investment models to founders. Learn how each firm thinks about scientific risk, team, and path to clinic—and what sets them apart. A must-attend for anyone looking to raise capital or understand today’s biotech venture landscape.
Date, time and room information
May 6, 09:00-09:45, room Marriott 3+4+5
Moderation
| Name | Position | Institution |
|---|---|---|
| Nina Kreymborg | SVP, CSO Partner Team | Curie.Bio |
Pitching companies
| Company name | Pitcher | Title of presentation | Link to company website |
|---|---|---|---|
| Curie.Bio | Lazar Bojic | http://curie.bio/ | |
| Versant Ventures | Markus Enzelberger | https://www.versantventures.com/ | |
| Forbion | Daniel Bode | https://forbion.com/en/ | |
| BioGeneration Ventures (BGV) | Daniela Couto | https://biogenerationventures.com/en/ | |
| Medicxi | Marco Prunotto | https://www.medicxi.com/ |
Jury members
| Name | Position | Institution |
|---|---|---|
| Patrick Amstutz | CEO | Molecular Partners |
| Lars Spenger | CFO | Memo |
| Dominik Hartl | CMO | Granite Bio |
